Infectious Agents Associated Cancers Epidemiology and Molecular Biology

(Nora) #1

89



  1. Iizasa H, Wulff BE, Alla NR, Maragkakis M, Megraw M, Hatzigeorgiou A, Iwakiri D, Takada
    K, Wiedmer A, Showe L, Lieberman P, Nishikura K (2010) Editing of Epstein-Barr virus-
    encoded BART6 MicroRNAs controls their Dicer targeting and consequently affects viral
    latency. J Biol Chem 285:33358–33370

  2. Ye YF, Zhou Y, Zhang L, Chen YX, Lyu XM, Cai LM, Lu YY, Deng Y, Wang JG, Yao KT, Fang
    WY, Cai HB, Li X (2013) EBV-miR-BART1 is involved in regulating metabolism-associated
    genes in nasopharyngeal carcinoma. Biochem Bioph Res Co 436:19–24

  3. Temple RM, Zhu J, Budgeon L, Christensen ND, Meyers C, Sample CE (2014) Efficient
    replication of Epstein-Barr virus in stratified epithelium in vitro. Proc Natl Acad Sci U S A
    111:16544–16549

  4. Tsang CM, Zhang G, Seto E, Takada K, Deng W, Yip YL, Man C, Hau PM, Chen H, Cao Y, Lo
    KW, Middeldorp JM, Cheung AL, Tsao SW (2010) Epstein-Barr virus infection in immortal-
    ized nasopharyngeal epithelial cells: regulation of infection and phenotypic characterization.
    Int J Cancer 127:1570–1583

  5. Zhu DD, Zhang J, Deng W, Yip YL, Lung HL, Tsang CM, Law WT, Yang J, Lau VMY, Shuen
    WH, Lung ML, Cheung ALM, Tsao SW (2016) Significance of NF-kappa B activation in
    immortalization of nasopharyngeal epithelial cells. Int J Cancer 138:1175–1185

  6. Shay JW, Roninson IB (2004) Hallmarks of senescence in carcinogenesis and cancer therapy.
    Oncogene 23:2919–2933

  7. Kondoh H, Lleonart ME, Bernard D, Gil J (2007) Protection from oxidative stress by enhanced
    glycolysis; a possible mechanism of cellular immortalization. Histol Histopathol 22:85–90

  8. Albini A, Sporn MB (2007) The tumour microenvironment as a target for chemoprevention.
    Nat Rev Cancer 7:139–147

  9. Justus CR, Dong L, Yang LV (2013) Acidic tumor microenvironment and pH-sensing G
    protein- coupled receptors. Front Physiol 4:354

  10. Hirschhaeuser F, Sattler UG, Mueller-Klieser W (2011) Lactate: a metabolic key player in
    cancer. Cancer Res 71:6921–6925

  11. Dhup S, Dadhich RK, Porporato PE, Sonveaux P (2012) Multiple biological activities of lactic
    acid in cancer: influences on tumor growth, angiogenesis and metastasis. Curr Pharm Design
    18:1319–1330

  12. Schwickert G, Walenta S, Sundfor K, Rofstad EK, Mueller-Klieser W (1995) Correlation
    of high lactate levels in human cervical cancer with incidence of metastasis. Cancer Res
    55:4757–4759

  13. Walenta S, Wetterling M, Lehrke M, Schwickert G, Sundfor K, Rofstad EK, Mueller-Klieser
    W (2000) High lactate levels predict likelihood of metastases, tumor recurrence, and restricted
    patient survival in human cervical cancers. Cancer Res 60:916–921

  14. Walenta S, Mueller-Klieser WF (2004) Lactate: mirror and motor of tumor malignancy. Semin
    Radiat Oncol 14:267–274

  15. Yang L, Liu L, Xu Z, Liao W, Feng D, Dong X, Xu S, Xiao L, Lu J, Luo X, Tang M, Bode
    AM, Dong Z, Sun L, Cao Y (2015) EBV-LMP1 targeted DNAzyme enhances radiosensitivity
    by inhibiting tumor angiogenesis via the JNKs/HIF-1 pathway in nasopharyngeal carcinoma.
    Oncotarget 6:5804–5817

  16. Sakakibara S, Tosato G (2009) Regulation of angiogenesis in malignancies associated with
    Epstein-Barr virus and Kaposi’s sarcoma-associated herpes virus. Future Microbiol 4:903–917

  17. Jonigk D, Izykowski N, Maegel L, Schormann E, Ludewig B, Kreipe H, Hussein K (2014)
    Tumour angiogenesis in Epstein-Barr virus-associated post-transplant smooth muscle tumours.
    Clin Sarcoma Res 4:1

  18. Ning S (2011) Innate immune modulation in EBV infection. Herpesviridae 2:1

  19. Munz C, Moormann A (2008) Immune escape by Epstein-Barr virus associated malignancies.
    Semin Cancer Biol 18:381–387

  20. Merlo A, Turrini R, Dolcetti R, Martorelli D, Muraro E, Comoli P, Rosato A (2010) The inter-
    play between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy
    of EBV-related disorders. Haematol-Hematol J 95:1769–1777


6 EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma

Free download pdf